Elizabeth Plumhoff

822 total citations
21 papers, 551 citations indexed

About

Elizabeth Plumhoff is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Elizabeth Plumhoff has authored 21 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 6 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in Elizabeth Plumhoff's work include Platelet Disorders and Treatments (13 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Blood groups and transfusion (4 papers). Elizabeth Plumhoff is often cited by papers focused on Platelet Disorders and Treatments (13 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Blood groups and transfusion (4 papers). Elizabeth Plumhoff collaborates with scholars based in United States, Canada and Australia. Elizabeth Plumhoff's co-authors include Catherine P.M. Hayward, Karen A. Moffat, Sara J. Israels, James L. Zehnder, William L. Nichols, Anne Raby, Piet Meijer, Dennis A. Gastineau, Vilmarie Rodriguez and Elizabeth M. Van Cott and has published in prestigious journals such as Blood, JNCI Journal of the National Cancer Institute and Journal of Clinical Microbiology.

In The Last Decade

Elizabeth Plumhoff

21 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Plumhoff United States 13 352 132 96 86 80 21 551
Véronique Le Cam‐Duchez France 13 346 1.0× 115 0.9× 47 0.5× 41 0.5× 111 1.4× 33 582
Yoshinobu Seki Japan 14 371 1.1× 107 0.8× 56 0.6× 111 1.3× 191 2.4× 53 756
IJ Mackie United Kingdom 13 199 0.6× 90 0.7× 49 0.5× 42 0.5× 110 1.4× 38 577
Oluwatoyosi A. Onwuemene United States 10 169 0.5× 51 0.4× 103 1.1× 38 0.4× 69 0.9× 42 454
J.Fredrik Hesselvik Sweden 8 151 0.4× 107 0.8× 44 0.5× 110 1.3× 59 0.7× 18 536
L. Crippa Italy 14 291 0.8× 255 1.9× 41 0.4× 56 0.7× 406 5.1× 24 743
Luis J. Garcia‐Frade Spain 8 214 0.6× 29 0.2× 30 0.3× 75 0.9× 41 0.5× 12 473
Terry K. Rosborough United States 13 167 0.5× 200 1.5× 25 0.3× 45 0.5× 207 2.6× 32 512
Anna Ågren Sweden 14 175 0.5× 347 2.6× 54 0.6× 60 0.7× 270 3.4× 28 718
Emily Rimmer Canada 10 172 0.5× 44 0.3× 62 0.6× 61 0.7× 58 0.7× 39 565

Countries citing papers authored by Elizabeth Plumhoff

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Plumhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Plumhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Plumhoff more than expected).

Fields of papers citing papers by Elizabeth Plumhoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Plumhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Plumhoff. The network helps show where Elizabeth Plumhoff may publish in the future.

Co-authorship network of co-authors of Elizabeth Plumhoff

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Plumhoff. A scholar is included among the top collaborators of Elizabeth Plumhoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Plumhoff. Elizabeth Plumhoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hollestelle, Martine J., et al.. (2022). Diagnostic Testing for von Willebrand Disease: Trends and Insights from North American Laboratories over the Last Decade. Seminars in Thrombosis and Hemostasis. 48(6). 700–710. 9 indexed citations
3.
Cott, Elizabeth M. Van, et al.. (2021). Diagnosis of von Willebrand disease: An assessment of the quality of testing in North American laboratories. Haemophilia. 27(6). e713–e720. 13 indexed citations
4.
Hayward, Catherine P.M., et al.. (2019). Update on diagnostic testing for platelet function disorders: What is practical and useful?. International Journal of Laboratory Hematology. 41(S1). 26–32. 22 indexed citations
5.
Smock, Kristi J., Elizabeth Plumhoff, Piet Meijer, et al.. (2016). Protein S testing in patients with protein S deficiency, factor V Leiden, and rivaroxaban by North American Specialized Coagulation Laboratories. Thrombosis and Haemostasis. 116(7). 50–57. 18 indexed citations
6.
Zantek, Nicole D., Piet Meijer, Kristi J. Smock, et al.. (2015). Quality of factor XI activity testing in North American Specialized Coagulation Laboratories. International Journal of Laboratory Hematology. 37(S1). 99–107. 7 indexed citations
7.
Hayward, Catherine P.M., Karen A. Moffat, Elizabeth Plumhoff, & Elizabeth M. Van Cott. (2012). Approaches to investigating common bleeding disorders: An evaluation of North American coagulation laboratory practices. American Journal of Hematology. 87(S1). S45–50. 24 indexed citations
8.
9.
Pai, Menaka, Karen A. Moffat, Elizabeth Plumhoff, & Catherine P.M. Hayward. (2011). Critical Values in the Coagulation Laboratory. American Journal of Clinical Pathology. 136(6). 836–841. 21 indexed citations
10.
Hayward, Catherine P.M., Karen A. Moffat, Anne Raby, et al.. (2010). Development of North American Consensus Guidelines for Medical Laboratories That Perform and Interpret Platelet Function Testing Using Light Transmission Aggregometry. American Journal of Clinical Pathology. 134(6). 955–963. 127 indexed citations
11.
Hayward, Catherine P.M., et al.. (2009). Results of an External Proficiency Testing Exercise on Platelet Dense-Granule Deficiency Testing by Whole Mount Electron Microscopy. American Journal of Clinical Pathology. 131(5). 671–675. 41 indexed citations
12.
Pai, Menaka, Karen A. Moffat, Elizabeth Plumhoff, et al.. (2009). Critical Values in the Coagulation Laboratory: Results of a Survey of the North American Specialized Coagulation Laboratory Association.. Blood. 114(22). 1415–1415. 4 indexed citations
13.
Nichols, William L., et al.. (2008). Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh‐frozen plasma. Transfusion. 49(4). 765–770. 54 indexed citations
14.
Moffat, Karen A., et al.. (2008). Are laboratories following published recommendations for lupus anticoagulant testing?. Thrombosis and Haemostasis. 101(1). 178–184. 23 indexed citations
15.
Pruthi, Rajiv K., et al.. (2007). Molecular analysis in a patient with severe factor VII deficiency and an inhibitor: report of a novel mutation (S103G). European Journal Of Haematology. 79(4). 354–359. 12 indexed citations
16.
Elliott, Michelle A., William L. Nichols, Elizabeth Plumhoff, et al.. (2003). Posttransplantation Thrombotic Thrombocytopenic Purpura: A Single-Center Experience and a Contemporary Review. Mayo Clinic Proceedings. 78(4). 421–430. 83 indexed citations
17.
Hogan, William J., Robert D. McBane, Paula J. Santrach, et al.. (2000). Antiphospholipid Syndrome and Perioperative Hemostatic Management of Cardiac Valvular Surgery. Mayo Clinic Proceedings. 75(9). 971–976. 32 indexed citations
18.
Wen, Deyong, et al.. (1994). A fluorescence-conjugated immunobinding assay for the detection of P-selectin on platelets.. PubMed. 124(3). 447–54. 2 indexed citations
19.
Silverstein, M. N., et al.. (1993). Suramin Toxicity and Efficacy in Agnogenic Myeloid Metaplasia. JNCI Journal of the National Cancer Institute. 85(18). 1520–1522. 12 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Véronique Le Cam‐Duchez Breakdown of academic impact, for papers by Yoshinobu Seki Breakdown of academic impact, for papers by IJ Mackie Breakdown of academic impact, for papers by Oluwatoyosi A. Onwuemene Breakdown of academic impact, for papers by J.Fredrik Hesselvik Breakdown of academic impact, for papers by L. Crippa Breakdown of academic impact, for papers by Luis J. Garcia‐Frade Breakdown of academic impact, for papers by Terry K. Rosborough Breakdown of academic impact, for papers by Anna Ågren Breakdown of academic impact, for papers by Emily Rimmer
Rankless by CCL
2026